Favipiravir began to arrive in the Russian hospital

In the Russian hospital received the first batch of the drug favipiravir (TN Aviewer), stated in a press release GK “Khimrar” and the Russian direct investment Fund (RDIF).

According to the report, the drug received the clinic and authorized pharmaceutical organizations of Moscow, Leningrad, Novgorod, Kirov, Nizhny Novgorod regions, the Republic of Tatarstan and Ekaterinburg. In June, the Russian hospitals must obtain 60 thousand courses of the drug.

29 may drug Aviewer produced by the company “Chemrar” was registered by the Ministry of health of the Russian Federation under the accelerated procedure – a drug recommended for the treatment of coronavirus infection (COVID-19). Favipiravir included in version 7 of the clinical recommendations for the treatment of coronavirus infection, the Ministry of health.

According to the CEO of RDIF, Kirill Dmitriev, the manufacturer of Avifauna received requests for delivery of the drug in more than 10 countries.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]